Faricimab for treating visual impairment caused by macular oedema after retinal vein occlusion. NICE technology appraisal guidance 1004
National Institute for Health and Care Excellence (NICE)
Record ID 32018013319
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/ta1004
Year Published:
2024
URL for published report:
https://www.nice.org.uk/guidance/ta1004
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England
MeSH Terms
- Retinal Vein Occlusion
- Macular Edema
- Angiogenesis Inhibitors
- Intravitreal Injections
- Visual Acuity
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.